Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.21.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Treasury Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2019     66,320,706 (13,479,000)            
Balance, at period start at Dec. 31, 2019 $ 867,576 $ (1,141) $ 331 $ (90,965) $ 1,037,141   $ (1,749) $ (75,664) $ (1,141) $ (1,518)
Increase (decrease) in shareholders' equity                    
Exercise of stock options (in shares)     357,974              
Exercise of stock options 3,408   $ 2   3,406          
Issuance of common stock - vesting of restricted stock units (in shares)     398,881              
Issuance of common stock - vesting of restricted stock units 2   $ 2              
Stock-based compensation expense 13,765       13,765          
Shares withheld to satisfy tax withholdings (in shares)       (130,164)            
Shares withheld to satisfy tax withholdings (9,199)     $ (9,199)            
Foreign currency translation loss, net of taxes (3,024)           (3,024)      
Net income (loss) (7,190)             (7,336)   146
Ending balance (in shares) at Mar. 31, 2020     67,077,561 (13,609,164)            
Balance, at period end at Mar. 31, 2020 864,197   $ 335 $ (100,164) 1,054,312   (4,773) (84,141)   (1,372)
Beginning balance (in shares) at Dec. 31, 2019     66,320,706 (13,479,000)            
Balance, at period start at Dec. 31, 2019 867,576 (1,141) $ 331 $ (90,965) 1,037,141   (1,749) (75,664) (1,141) (1,518)
Increase (decrease) in shareholders' equity                    
Transfer of non-controlling units 771                  
Foreign currency translation loss, net of taxes 290                  
Net income (loss) (10,338)                  
Ending balance (in shares) at Sep. 30, 2020     67,584,956 (13,700,057)            
Balance, at period end at Sep. 30, 2020 953,367   $ 337 $ (107,248) 1,150,198   (1,459) (87,155)   (1,306)
Beginning balance (in shares) at Mar. 31, 2020     67,077,561 (13,609,164)            
Balance, at period start at Mar. 31, 2020 864,197   $ 335 $ (100,164) 1,054,312   (4,773) (84,141)   (1,372)
Increase (decrease) in shareholders' equity                    
Exercise of stock options (in shares)     184,475              
Exercise of stock options 3,275   $ 1   3,274          
Issuance of common stock - vesting of restricted stock units (in shares)     134,207              
Issuance of common stock - vesting of restricted stock units 1   $ 1              
Stock-based compensation expense 13,006       13,006          
Shares withheld to satisfy tax withholdings (in shares)       (43,697)            
Shares withheld to satisfy tax withholdings (3,617)     $ (3,617)            
Transfer of non-controlling units 771       910         (139)
Foreign currency translation loss, net of taxes 1,575           1,575      
Net income (loss) (5,471)             (4,924)   (547)
Ending balance (in shares) at Jun. 30, 2020     67,396,243 (13,652,861)            
Balance, at period end at Jun. 30, 2020 873,737   $ 337 $ (103,781) 1,071,502   (3,198) (89,065)   (2,058)
Increase (decrease) in shareholders' equity                    
Exercise of stock options (in shares)     44,672              
Exercise of stock options 1,370       1,370          
Issuance of common stock - vesting of restricted stock units (in shares)     144,041              
Issuance of common stock - vesting of restricted stock units 0                  
Stock-based compensation expense 15,729       15,729          
Shares withheld to satisfy tax withholdings (in shares)       (47,196)            
Shares withheld to satisfy tax withholdings (3,467)     $ (3,467)            
Capital contribution - non-controlling interest 0       (339)         339
Issuance of Convertible Notes due 2025, net of offering costs and taxes of $8,617 61,936       61,936          
Foreign currency translation loss, net of taxes 1,739           1,739      
Net income (loss) 2,323             1,910   413
Ending balance (in shares) at Sep. 30, 2020     67,584,956 (13,700,057)            
Balance, at period end at Sep. 30, 2020 $ 953,367   $ 337 $ (107,248) 1,150,198   (1,459) (87,155)   (1,306)
Beginning balance (in shares) at Dec. 31, 2020 67,832,706   67,832,706 (13,739,171)            
Balance, at period start at Dec. 31, 2020 $ 975,818 (79,842) $ 339 $ (110,466) 1,166,774 $ (108,470) (398) (79,912) 28,628 (519)
Increase (decrease) in shareholders' equity                    
Exercise of stock options (in shares)     27,043              
Exercise of stock options 522       522          
Issuance of common stock - vesting of restricted stock units (in shares)     455,349              
Issuance of common stock - vesting of restricted stock units 2   $ 2              
Stock-based compensation expense 14,013       14,013          
Shares withheld to satisfy tax withholdings (in shares)       (147,041)            
Shares withheld to satisfy tax withholdings (9,541)     $ (9,541)            
Share repurchase (in shares)       (24,227)            
Share repurchase (1,672)     $ (1,672)            
Foreign currency translation loss, net of taxes (624)           (624)      
Other 118                 118
Net income (loss) 14,935             14,946   (11)
Ending balance (in shares) at Mar. 31, 2021     68,315,098 (13,910,439)            
Balance, at period end at Mar. 31, 2021 $ 913,729   $ 341 $ (121,679) 1,072,839   (1,022) (36,338)   (412)
Beginning balance (in shares) at Dec. 31, 2020 67,832,706   67,832,706 (13,739,171)            
Balance, at period start at Dec. 31, 2020 $ 975,818 $ (79,842) $ 339 $ (110,466) 1,166,774 $ (108,470) (398) (79,912) $ 28,628 (519)
Increase (decrease) in shareholders' equity                    
Exercise of stock options (in shares) 44,079                  
Transfer of non-controlling units $ 0                  
Foreign currency translation loss, net of taxes (1,618)                  
Net income (loss) $ 18,004                  
Ending balance (in shares) at Sep. 30, 2021 68,636,215   68,636,215 (14,018,311)            
Balance, at period end at Sep. 30, 2021 $ 947,075   $ 343 $ (129,877) 1,108,864   (2,016) (32,879)   2,640
Beginning balance (in shares) at Mar. 31, 2021     68,315,098 (13,910,439)            
Balance, at period start at Mar. 31, 2021 913,729   $ 341 $ (121,679) 1,072,839   (1,022) (36,338)   (412)
Increase (decrease) in shareholders' equity                    
Exercise of stock options (in shares)     4,082              
Exercise of stock options 51       51          
Issuance of common stock - vesting of restricted stock units (in shares)     140,082              
Issuance of common stock - vesting of restricted stock units 1   $ 1              
Stock-based compensation expense 17,161       17,161          
Shares withheld to satisfy tax withholdings (in shares)       (46,699)            
Shares withheld to satisfy tax withholdings (3,479)     $ (3,479)            
Share repurchase (in shares)       (6,261)            
Share repurchase (425)     $ (425)            
Capital contribution - non-controlling interest 23       (788)         811
Foreign currency translation loss, net of taxes (1,264)           (1,264)      
Other 38                 38
Net income (loss) (8,369)             (8,281)   (88)
Ending balance (in shares) at Jun. 30, 2021     68,459,262 (13,963,399)            
Balance, at period end at Jun. 30, 2021 917,466   $ 342 $ (125,583) 1,089,263   (2,286) (44,619)   349
Increase (decrease) in shareholders' equity                    
Exercise of stock options (in shares)     12,954              
Exercise of stock options 347       347          
Issuance of common stock - vesting of restricted stock units (in shares)     163,999              
Issuance of common stock - vesting of restricted stock units 1   $ 1              
Stock-based compensation expense 18,760       18,760          
Shares withheld to satisfy tax withholdings (in shares)       (54,912)            
Shares withheld to satisfy tax withholdings (4,294)     $ (4,294)            
Capital contribution - non-controlling interest 3,178       661         2,517
Foreign currency translation loss, net of taxes 270           270      
Other (91)       (167)         76
Net income (loss) $ 11,438             11,740   (302)
Ending balance (in shares) at Sep. 30, 2021 68,636,215   68,636,215 (14,018,311)            
Balance, at period end at Sep. 30, 2021 $ 947,075   $ 343 $ (129,877) $ 1,108,864   $ (2,016) $ (32,879)   $ 2,640